{"bill":{"bill_id":1687059,"change_hash":"61f5b3826f59c77dc65d5bde62cc1ed4","session_id":2002,"session":{"session_id":2002,"state_id":42,"year_start":2023,"year_end":2024,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023-2024 Regular Session","session_name":"113th General Assembly"},"url":"https:\/\/legiscan.com\/TN\/bill\/SB0733\/2023","state_link":"https:\/\/wapp.capitol.tn.gov\/apps\/Billinfo\/default.aspx?BillNumber=SB0733&ga=113","completed":0,"status":1,"status_date":"2023-01-30","progress":[{"date":"2023-01-30","event":1}],"state":"TN","state_id":42,"bill_number":"SB0733","bill_type":"B","bill_type_id":"1","body":"S","body_id":90,"current_body":"S","current_body_id":90,"title":"AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine.","description":"As introduced, prohibits a healthcare provider from prescribing a buprenorphine product unless the patient has first signed a copy of an informational document on the risks of buprenorphine use to pregnant women, unborn children, and infants; requires the department of health to make available on its public website the informational document within 90 days of the effective date of the act. - Amends TCA Title 53 and Title 63.","pending_committee_id":2648,"committee":{"committee_id":2648,"chamber":"S","chamber_id":90,"name":"Health and Welfare"},"referrals":[{"date":"2023-02-06","committee_id":2648,"chamber":"S","chamber_id":90,"name":"Health and Welfare"}],"history":[{"date":"2023-01-30","action":"Filed for introduction","chamber":"S","chamber_id":90,"importance":1},{"date":"2023-02-02","action":"Introduced, Passed on First Consideration","chamber":"S","chamber_id":90,"importance":0},{"date":"2023-02-06","action":"Passed on Second Consideration, refer to Senate Health and Welfare Committee","chamber":"S","chamber_id":90,"importance":0}],"sponsors":[{"people_id":7282,"person_hash":"d6u7qa30","party_id":"2","state_id":42,"party":"R","role_id":2,"role":"Sen","name":"Rusty Crowe","first_name":"Rusty","middle_name":"","last_name":"Crowe","suffix":"","nickname":"","district":"SD-003","ftm_eid":6607266,"votesmart_id":24342,"opensecrets_id":"","knowwho_pid":198964,"ballotpedia":"Rusty_Crowe","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":5,"type":"Crossfiled","sast_bill_number":"HB0665","sast_bill_id":1682887}],"subjects":[{"subject_id":321387,"subject_name":"Opioids"}],"texts":[{"doc_id":2671059,"date":"2023-01-30","type":"Draft","type_id":9,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/TN\/text\/SB0733\/id\/2671059","state_link":"https:\/\/www.capitol.tn.gov\/Bills\/113\/Bill\/SB0733.pdf","text_size":8984,"text_hash":"d712a734cd203315689338bdbc12fc9d"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}